In the evolving landscape of pharmaceutical manufacturing, decarbonization has emerged as a critical imperative for Contract Development and Manufacturing Organizations too. This session will explore the significance of integrating decarbonization strategies within the continuous improvement framework that CDMOs should adopt in order for both CDMOs and Pharma companies to meet their climate targets. As the pharmaceutical industry faces increasing pressure to reduce its carbon footprint, the adoption of sustainable practices is not merely a regulatory requirement but a pathway to innovation and operational excellence.
By engaging and prioritizing sustainable practices, CDMOs can not only meet the demands of environmentally conscious stakeholders but also drive competitive advantage in a rapidly changing market. The discussion will highlight actionable strategies for embracing and implementing decarbonization initiatives and fostering a culture of sustainability as part of their commitment to continuous improvement in order to be positioned as leaders in the pharmaceutical manufacturing sector and as preferred suppliers for the Pharma.
Check out the incredible speaker line-up to see who will be joining Spyros.
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.